Sixfold Bioscience is a biotechnology startup headquartered in the United Kingdom. Founded in 2018, the company focuses on RNA delivery. Their recent achievement includes a significant $8.30M grant investment secured on 2nd December 2021. The investment came from notable backers including Innovate UK, MedCity News, and the European Commission.
With their slogan "RNA delivery, evolved," Sixfold Bioscience is positioning itself as a pioneer in the health and wellness sector. Their innovative approach to RNA delivery holds great potential for addressing critical medical needs and advancing biotechnological solutions. The recent injection of funds is expected to propel their research and development efforts, solidifying their stance in the competitive biotech landscape.